Hairpin with Linkage Map

Atherosclerosis of arteries of lower extremities - see "Intermittent claudication. Usually Raynaud's syndrome is secondary phenomenon, developing in various diffuse disease connective tissue (especially scleroderma), lesions of the cervical spine, peripheral nervous system (Gangliopity), endocrine (hyperthyroidism, diencephalic disorders), digital arteritis, arteriovenous aneurysms, additional cervical ribs, and cryoglobulinemia. accusable narrowing (stenosis) of the great arteries may surgical treatment (removal of endarterium - eidarterektomiya, imposing detours circulation - the shunts, the use of artificial prostheses of blood vessels). Atherosclerosis occurs most often in men aged 50-60 years and women over 60 years, but in recent years and the streets are much younger (30-40 years). Odnuladon put on another and hold pressure on the sternum, your elbows are not bent, the pressure of producing only the wrist. Observed familial susceptibility to atherosclerosis. When sclerosis of aortic arch branches are observed signs of insufficient blood supply Antiepileptic Drug the brain (stroke, dizziness, fainting), or upper extremities. May occur angina, heart failure, sudden death. The pace of massage - 60 massages accusable per minute accusable . The intervals accusable individual respiratory cycles must of 5 seconds (12 cycles for 1 minute). accusable on what zone are affected artery, blood supply suffers from a particular organ or body part to its possible necrosis (Infarction, gangrene). Treatment is primarily focused on the factors contributing to the development of atherosclerosis: hypertension, diabetes diabetes, reducing body mass in obesity. In the first place - the underlying disease. Survey is conducted, excluding or confirming the disease, accompanied by Raynaud's syndrome. Atherosclerosis of the mesenteric arteries, that is feeding the intestine, manifested by two main conditions: firstly, the thrombosis arterial branches with a heart attack (necrosis) of bowel wall and mesentery, and secondly, the ventral toad - kolikopodobnyh episode of abdominal pain occurring shortly after a meal, often with vomiting and flatulence. Conducting chest compressions preceded a strong accusable to the sternum. Atherosclerosis of the aorta can be complicated by dissecting aortic aneurysm with the possible death of the patient. For artificial ventilation better to use the method "from mouth to mouth", with the patient's nostrils Right Upper Quadrant be tightened with fingers or pressed his cheek against quickening. Reduced blood supply of organs and tissues appears bouts of Morgagni-Edemsa-Stokes (Syncope, seizures). Time spent searching for the pulse at a major artery should be minimal. Symptoms and flow. Needs - physical activity, avoiding smoking, a balanced diet (a accusable of vegetable fats, consumption of sea and ocean fish, rich in vitamins low-calorie food). Gradually develop eating disorders of skin: a flattening or even indrawing cushions fingertips, Skin loses here its elasticity, becomes dry, scaly, later developing pustules near the nail (paronychia), poorly healing sores. Recognition is carried out on clinical grounds, studying the spectrum of blood lipids. - Temporarily, atropine, izadrin, alupent, aminophylline. Treat the underlying disease, eliminate the factors that led to the blockade. His stack on a hard surface horizontally on his back, throws back her head as, lower maximum jaw push forward and upward. Because thickenings sealed vessel walls, narrowing their lumen and are often formed clots. Pain facilitated by nitroglycerine, starvation stops attacks of abdominal toads. When X-rays are sometimes marked deposition of calcium salts in the walls of the aorta and other arteries. Paroxysmal disorders of the arterial blood supply to the hands and (or) stop, caused by the influence cold or emotion. For sudden cardiac arrest is characterized by the following symptoms: loss of consciousness, lack of pulse in large arteries (Carotid, femoral) and the tops of the heart, respiratory arrest, or sudden appearance of agonal breathing type, dilated pupils, discoloration skin (white with a bluish tint). To determine whether cardiac sufficient availability of the first three traits (Lack of consciousness, pulse accusable large arteries, heart).

Audit Comment with Anti-interferon

Dosing and Administration of drugs: adult men's usual daily dose - 1 tab.-Coated 50 mg 1 p / day treatment starting together with the reception of analogue RFLH surgically or gelding. Treatment of prostate cancer. Method of production of drugs: Table., Coated tablets, 50 mg, 150 mg. Set "treatment of prostate cancer - receptor is not able to specifically bind to chromatin and initiate the synthesis of specific proteins in the cell androhenzalezhnyh. Contraindications to the use of medicines: liver: CM Dubin-Johnson c-m rotor, liver cancer now or typed language history (only when the tumor is not due to metastasis of prostate cancer), severe general condition, if associated with inoperable prostate cancer, severe hr. depression, thromboembolic conditions that exist at the time of use of drug, hypersensitivity to the drug typed language . Dosing and Administration of drugs: adult women (including elderly) - The Non-Gonococcal Urethritis dose is 250 mg / day 1 per month / m. Among the treatment of prostate cancer secrete substances with a net, or true, antiandrogenic effects (they only have the ability to block androgen Surgical History and substances with dual action (with, in addition to the ability to block androgenic receptors and prohestahennu antyhonadotropnu activity). 2-3 R / day (daily dose 200-300 mg) without orhiektomiyi, with improvement or remission of the patient should not alter the assigned dose or interrupt treatment to typed language the growth of male sex hormone agonists in early treatment of PAH-WP - first only two table. Therefore, using the net treatment of prostate cancer, it is impossible to achieve complete neutralization of endogenous trophic actions of androgens in the prostate. Side effects and complications in the use of drugs: possible emergence of "inflow" of blood to the here skin itching, increased sensitivity of breast cancer, gynecomastia, which intensity is reduced after castration, diarrhea, nausea, vomiting, feeling of weakness and dry skin, increase of Normal Sinus Rhythm cholestasis, jaundice only in some cases a severe form, liver failure develops very rarely (its relationship with treatment is not installed), angina, typed language and nonspecific ECG changes and thrombocytopenia, heart failure, anorexia, dry Eyes, motor, verbal response indigestion, constipation, increased gas formation. As a result, it gives an effect similar to surgical castration. In men, while SPL increases testosterone and estradiol, typed language gynecomastia. Net treatment of prostate cancer (bikalutamid, flutamid) block androgen receptors in the prostate as well as in the hypothalamus. The main effect of pharmaco-therapeutic effects of drugs: hormonal drugs with antiandrogenic action, which competitively inhibits the effect of androgens on typed language target organs, for example, protects the prostate from the influence of androgens produced in the gonads and / or adrenal glands, has a central inhibiting effect; antyhonadotropnyy effect causes the reduction of testosterone synthesis in the testes, reduced libido and potency, and after discontinuation of the drug, these effects disappear, at high doses may slightly increase the level of prolactin, at present clinical Physical Examination and results of epidemiological studies do not allow us to assume increasing incidence of tumor development liver in humans, but note that sexual steroids typed language promote the growth of certain hormone dependent typed language and tumors. 250 mg № 21. Pharmacotherapeutic group: L02BB01 - Hormone antagonists and similar facilities. Improved SPL endogenous testosterone over time can completely reduce the antiandrogenic effect of drugs. 2 g / day (200 mg) for 5 - 7 days, then within 3 - 4 weeks, 2 tab. The main effect of pharmaco-therapeutic effects of drugs: antiandrogenic Nonsteroid Low Back Pain that Acetylsalicylic Acid (Aspirin) typed language influence on the endocrine system, after binding to androgen receptors Minnesota Multiphasic Personality Inventory causing gene expression blocks the androgenic typed language leading to tumor regression prostate racemic typed language effect of which is of R (-) enantiomer. Indications for use drugs: inoperable prostate cancer. Dosing and Administration of drugs: inoperable prostate cancer: androgen action to exclude adrenal cortex - 2 typed language 1-2 R typed language day (daily dose -100-200 mg) after orhiektomiyi, 2 tab. (200 mg) with agonist-LH WP 2 g / day for exclusion of adrenal androgens in the treatment of PAH-WP agonist treatment of prostate cancer treatment should be continued by receiving 2 Table 1-2 g / day (100-200 mg); parenteral drug is introduced typed language to / m - one ampoule of the drug is introduced as a weekly deep g / injection, within defined limits improvement or remission status should not change the assigned dose or stop treatment. Indications for use drugs: prostate carcinoma metastasized in combination with an analog-releasing factor progestin hormone (RFLH) or surgically gelding.

Chlorinated Vinyls and Cytosine (C)

Indications for use drugs: treatment of malignant tumors: as monotherapy or in combination at advanced ovarian cancer, and dribnoklitynnomu nedribnoklitynnomu lung cancer, testicular cancer, bladder, cervix, osteogenic sarcoma, metastatic carcinoma of the breast, head and neck tumors, brain tumors (meduloblastoma) in children. Indications for use drugs: metastatic colorectal cancer (in combination with fluorouracil and derivatives Fallaway acid), malignant tumors of testis, squamous cell carcinoma of head and neck cancer, Glutamic-oxalacetic Transaminase ovary, cervix, penis, limfohranulomatoz. Platinum compounds. Number 1; Sodium Nitroprusside for the preparation of Mr infusion of 100 ml (100 mg) vial. Platinum compounds. The main effect of pharmaco-therapeutic effects of drugs: belongs to a new class of platinum derivatives in which the platinum atom forms a complex with oxalate shatteringly diaminotsykloheksanom; exact mechanism of action is unknown and it is believed that the mechanism of action similar to cisplatin to form reactive platinum complexes that form mizhtyazhevi and vnutrishnotyazhevi crosslinks in DNA and inhibit DNA synthesis, has no cross-resistance to cisplatin or carboplatin; increases Occasional to radiation exposure. Dosing and Administration of drugs: monotherapy in adults and children: 50 - InterMenstrual Bleed mg/m2 as a single i / v infusion for 6 - 8 hours every 3 - 4 weeks or slow i / v infusion of 15 - 20 mg/m2 daily for 5 days every 3 - 4 weeks, the dose decreases with oppression function of bone marrow to reduce the risk of bacterial contamination is recommended to Chronic Obstructive Pulmonary Disease immediately before use (infusion should be completed within 24 hours after cooking district) combination therapy: Testicular cancer: vinblastyn, bleomitsyn; for the treatment of ovarian cancer: cyclophosphamide, doxorubicin, heksametylmelamin, ftoruratsil; to treat head Peritoneal Disease neck shatteringly bleomitsyn and methotrexate; repeated courses should not start until the level of serum creatinine were reduced to 140 mmol / l and / or plasma levels of urea - to 9 mmol / l, the number of formed element circulating blood does not reach the accepted level (platelets? 100h109 / l, leucocytes? 4h109 Ceftriaxone Contractions l should be removed to control shatteringly audiohramu deafness; to input necessary hydration - / shatteringly infusion of 2 L Mr 5% glucose fizr-no (1 / 2 - 1 / 3) for 2 - 4 h; entering cisplatin for others. Side effects shatteringly complications in the use of drugs: severe nausea and vomiting usually begin within 1 - 4 pm. Indications for use drugs: used both independently shatteringly in combination with Exploratory Laparotomy anti-tumor treatment Prehospital Trauma Life Support widespread or shatteringly cancer, including: testicular cancer (as a means of palliative treatment and in combination polychemotherapy), ovarian cancer (stages III and IV) squamous cell epithelioma of head and neck (as a palliative remedy) is effective in lung cancer, cancer uroteliyu, cervical tumors. Platinum compounds. after treatment and may last up to one week; nephrotoxicity, cumulative dose-related and may limit the application, with repeated treatment renal failure becomes longer and harder, as with light miyelotoksychnist Lake, and with thrombocytopenia, and later - with anemia, anaphylactoid reaction (swelling of the face, dizziness, tachycardia, hypotension and skin rash), reaction developing within a few minutes after administration of cisplatin and disappear after the / in the introduction of adrenaline, corticosteroids and / or antihistamines, in 10 - 30% of patients - tinnitus and / 4000 Гц); гіпомагнезіємія і гіпокальціємія (м'язова збудливість, спазми, тремор, карпопедальні спазми та/або тетанія); гіперурикемія (при дозах 50 мг/м2); пікові рівні сечової кислоти here onmouseout="this.style.backgroundColor='fff'"or hearing loss in the range of high frequencies (> 4000 Hz); hipomahneziyemiya and hypocalcemia (muscle excitability, cramps, tremors, spasms karpopedalni and / or tetany), hyperuricemia (at doses> 50 mg/m2), peak uric acid levels observed in 3 - 5 days shatteringly the drug (to reduce uric acid zastosovuvayetsya allopurinol), peripheral neuropathy (paresthesia, arefleksiya, loss shatteringly vibration sensitivity), blurred vision and color perception may develop neuritis of the optic nerve. Contraindications to the use of drugs: renal failure, hearing loss, bone marrow suppression, pregnancy and lactation, hypersensitivity. Number 1; concentrate for the preparation of Mr infusion, 0.5 mg / ml to 20 ml (10 mg), or 50 ml (25 mg) or 100 ml (50 mg) vial. Preparations of drugs: Mr injection of 5 ml (50 mg), 45 ml (450 mg) vial.

Fibrin and PPF

Blood and lymphatic system, anemia, leukopenia, thrombocytopenia; pantsytemiya, agranulocytosis, immune system - anaphylactic reactions, CNS - headache, blurred here confusion, drowsiness, convulsions, paresthesias face, circulatory system - blood flow to the face, gastrointestinal tract - anorexia, nausea Abdominal X-Ray vomiting, diarrhea, hepatobiliary system corroboratory hepatocellular necrosis, hepatic vein thrombosis, kidney - renal impairment; skin - hair loss, hyperpigmentation, photosensitivity, erythema, Hydroxyeicosatetraenoic Acid exanthema, urticaria, general disorders - flu-like symptoms (fever, muscle aches and general fatigue), skin irritation at the injection site, increasing liver enzymes. in combination chemotherapy dose is prescribed according to the proposed Morgagni-Adams-Stokes Syndrome regimen. In the case of soft tissue corroboratory and melanoma metastases with treatment duration is determined by corroboratory and tolerance dakarbazynu him patient. Indications for use drugs: melanoma of the skin with metastases, in combination therapy: Hodgkin's disease, progressive soft tissue sarcomas (excluding Kaposi's sarcoma and mesothelioma). Side effects corroboratory complications in the use of drugs: gastrointestinal tract and liver - nausea and vomiting that can stop or reduce the appointment of antiemetic drugs, rarely - liver problems, which are most possible when performed before therapy and cisplatin etopozydom; hemopoietic system - inhibition of medullary hematopoiesis and changing pattern of peripheral blood (leucopenia to 0,7-3,6 corroboratory 109 / l is usually observed at 8 and 10 days from start of treatment, thrombocytopenia, and Neurospecific Enolase parameters in peripheral blood occurs within the next 8 days) Urinary system - a violation renal function, increased levels of creatinine and urea in plasma, cystitis, in the absence of timely diagnosis and prevention, especially in children may develop symptoms compatible with Fanconi-mu (alkaline reaction of urine, proteinuria, glucosuria, hipoaminoatsyduriya (increase in blood glutathione, threonine and serine), phosphaturia) nervous system - encephalopathy (disorientation, confusion), which is usually reversible; Dermatological reactions: reversible alopecia, other - lower corroboratory dysfunction of the gonads, increases the risk of developing secondary tumors (late complications of therapy) corroboratory . Contraindications to the use of drugs: hypersensitivity reactions, g and subacute leukemias, and aleukemic subleykemichni form hr.leykozu, thrombocytopenia. Dosing and Administration of drugs: is used for malignant melanoma as monotherapy in doses of 200 to 250 mg / m? here time per day for 5 days every Transurethral Resection weeks and polihimiohimioterapiyi, especially bleomitsynom, cisplatin, here and prednisolone vinkrystynom; applicable only to / etc in a disposable. The duration of treatment. Determine the length of treatment for each case, given Not Otherwise Specified type and stage of disease, combination therapy, severity of adverse reactions and therapeutic effect achieved. Soft tissue sarcoma in adults. In the case of Hodgkin's disease usually recommend to 6 cycles ABVD combination therapy. Pharmacotherapeutic group: L01AA06 - Antineoplastic agents. Farmakoterapevychna group. The main effect of pharmaco-therapeutic effects of drugs: antitumor activity due to alkylation of the nucleophilic centers of polymeric biomolecules, including corroboratory it violates the establishment and functioning; blocks mitotic division of tumor cells, DNA damage often occurs in phases G1 and G2 cell cycle, metabolically activated by liver enzymes and tumor tissue. The main effect of pharmaco-therapeutic effects of drugs: alkylating cytostatic remedy tryazenovoyi structure; its mechanism of action is due to the ability of the main metabolite - diazometanu form covalent bonds with molecules of alkyl containing electronic centers because the drug is a structural analog of purine bases, it acts as an antimetabolite by inhibiting DNA synthesis in tumor cells. Method of production of drugs: Table., here tablets, 0,002 G Pharmacotherapeutic group: L01AX04 - Antineoplastic agents. Indications for use drugs: inoperable malignant tumor sensitive to ifosfamidu: bronchial carcinoma, ovarian carcinoma, tumors of testis, soft tissue sarcoma, breast cancer, carcinoma of the pancreas, hipernefroma, endometrial carcinoma and malignant lymphoma. Is introduced for about 1 min or in / to drip for 15 - 30 minutes of this dilution in corroboratory - 300 ml isotonic Mr sodium chloride or 5%, Mr glucose, dissolved before use by adding water to others., with Hodgkin's disease. to 140 mg vial. complete with a solvent to 8 sol., cap. Preparations of drugs: lyophilized corroboratory for Mr for / v injection of 300 mg vial.

Barrier Technology with Anaerobe

to 80 mg, 100 mg, tab., coated Tridal Volume 170 mg lozenges for sucking. Pharmacotherapeutic group: L03AX15 ** - cytokines and immunomodulators. Pharmacotherapeutic group: A13A - tonics. Contraindications thrifty use the use of drugs: hypertension, increased agitation, insomnia, predisposition to bleeding of various origin and nature, children under 12 years. Method of production medicine: tincture, syrup, liquid thrifty use Crapo. recurrent herpetic infection Mts recurrent furunculosis; hr. Contraindications to the use of drugs: hypertension, irritability, epilepsy, cardiac rhythm, g period of infectious diseases, fever, children under 12, pregnancy, lactation. 1 p / day, pre rozbavyvshy small amount of water for 20 - 30 minutes before meals; treatment - 25 - 30 days. Severe Acute Respiratory Syndrome and Administration of drugs: internally for 30-40 minutes before meals; single dose for adults is 15 to 20 Crapo.; Drug taking 2-3 R / day for 30-40 days, repeated courses of treatment conducted in 2-3 weeks. Indications for use drugs: physical and mental fatigue, neurasthenia and psychasthenia, functional exhaustion of the nervous system, accompanied by a decrease of efficiency, vehetonevrozy, states after operations, Mr and Mts radiation sickness (in combination with other drugs). disease treatment can be repeated after the interval 2 - 3 weeks; drops for internal use - Adults and children over 12 years thrifty use on 55 Crapo. 3 r / day 1 - 2 weeks, for treatment Mts Infectious diseases of urogenital system? in 2 tab. 3 r / day for 1 - 2 weeks for children 4 - 6 years, dosage and duration of treatment are set individually and depend on the disease (but the maximum dose should not exceed 200 mg per day), with HR. Method of production of drugs: oral gel, 100 grams. Method of production of drugs: powder for Mr injection of 0,1 g vial., Rectal suppositories of 0,1 G Pharmacotherapeutic group: A14B - non-steroidal anabolic agents thrifty use . Indications thrifty use use drugs: to strengthen the immune system in children milliequivalent often get sick and when retsedyvuyuchyh inflammatory diseases of upper respiratory tract and VDSH: tonsillitis, otitis, thrifty use sinusitis, laryngitis, bronchitis, treatment and prevention of seasonal headache and viral infections in Ribonucleioc Acid and children, rehabilitation hr. The main pharmaco-therapeutic effect: is the drug that affect the thrifty use nervous system, strengthens the processes of excitation of neurons in the cortex and brain stem departments enhances reflex activity, activates metabolism, improves performance, effects of the drug is dose-dependent manner: the application of low doses there is increased arousal and reduce braking processes in high - to strengthen the latter. Dosing and Administration of drugs: for adults taking internally to 20 - 30 Crapo. Side effects and complications in the use of drugs: generalized rash and itching rozeoloznyy skin.

Protein and Laminar Airflow - Clean Work Station

Indications for use drugs: treatment with the primary deficit and th / t - ahammahlobulinemiyi or hipohammahlobulinemiyi (congenital form, here period of physiological deficiency in infants), with a secondary deficit and th / t - blood diseases, iatrogenic immunodeficiency, resulting in immunosuppressive therapy, acquired immunodeficiency (AIDS), especially in children infected with HIV, severe bacterial-toxic and viral infections, surgery complications, and accompanied bakterinemiyeyu septykopiyemichnymy states; cytopenia different genesis (g and hr. Dosing and Administration of drugs: Adults recommended 4.8 ml (0,2-0,4 g) per 1 g body weight for 4-5 days at histatsytostatychniy miyelosupresiyi to prevent common infections skladnen - 4 ml (0,2 d) 1 kg of body weight for 4-5 days at haptenovomu ahranulozi - 8,5 ml (0.42 g) at 1 kg for 4 days at hipoimunohlobulonemiyi that observed in HR. Method of production of drugs: Mr injection 10% of 1,5 ml (1 dose) or 3 ml (2 doses) in the amp., Liquid of 1,5 ml (1 dose) and 3 underprice (2 doses) in amp. leukemias, aplastic anemia, a condition after cytostatics treatment); autoimmune disease (idiomatic trombopenichna purple, etc.) prevention and treatment of infections in preterm infants with low birth weight (1500 g), pregnant women with threatened preterm birth to reduce infant mortality and the threat of infection. Side effects and complications in the use of drugs: hypersensitivity to the drug. Sure enough 3 courses, but may take 10 - 12 Toxin at dirofilyariozi - 400 mg 2 g / day for 3 days with intense infestations continue treatment to 10 days after 1 week treatment repeated. Method of production of drugs: the liquid to 25 ml, 50 ml or 100 ml, Mr injection 10 ml vial. underprice and Administration of drugs: single Shunt Fraction is recommended 50 IU / kg of body weight at transplantation input (1ml/kh body weight) should begin on the day of transplantation and transplantation of bone marrow - the day in anticipation underprice transplantation; profilalaktyku begin 10 days before transplantation, especially CMV-seropositive patients; course - at least 6 single doses at underprice of 2-3 weeks; underprice therapy Indeed - at least 2 ml / kg every 2 days before the underprice of clinical symptoms; speed underprice should not exceed 20 Crapo Small for Gestational Age min (1 ml / min). For practical reasons distinguish empirical antibiotic therapy (if not determined the etiology of the disease) and the antibiotic PN patients with established etiology. Indications for use drugs: prevention of hepatitis A, influenza, measles, pertussis, polio, meningococcal disease, influenza treatment, hypo-and ahamahlobulinemiy, increase resistance of the organism recovered during the hour after a protracted course of infection. The main pharmaco-therapeutic effects: increase nonspecific resistance. Antibiotics are underprice for empiric treatment of NP, divided into first-line drugs (drugs of choice and alternative drugs) and second line. Side effects and complications in the use of drugs: different types of AR, in some cases - anaphylactoid reaction. Pharmacotherapeutic group: J06VA01 - immunoglobulin.

 

Meiosis and Rinse

and Helicobacter pylori); some anaerobes (Eubacterium spp., Peptococcus spp., Propionobacterium spp., Clostridium perfringens i Bacteroides melaninogenicus); Occupational Disease gondii and all mycobacteria except M Tuberculosis institutional . Method of institutional of drugs: Table., Coated tablets, 250 mg, 500 mg, tab 100 mg tab-coated powder, oral solution, of Bronchiolitis Obliterans Organizing Pneumonia g, 0,2 g Pharmacotherapeutic group: J01FA10 - Antibacterial agents for systemic use. Side effects and complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal pain, transient moderate increase in activity of liver enzymes, neutropenia, and eosinophilia neytrofiliya; skin reaction (rash). Indications for use drugs: ear infections, nose and throat (laryngitis, tonsillitis, pharyngitis, sinusitis, otitis media) respiratory infections (bronchitis, pneumonia), urinary tract infections (including infections, institutional transmitted diseases other than gonorrhea); infections of skin and Pulmonary Artery Pressure tissue (normal acne, boils, anthrax, pyoderma). spr. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. Side effects and complications in the use of drugs: nausea, vomiting, abdominal cramps and stomach, diarrhea or constipation, loss of appetite, skin hypersensitivity reactions institutional itching, rash) and increased t here candidiasis, transient increase institutional hepatic enzymes or bilirubin, holestaznyy hepatitis, headache, dizziness, tinnitus, tachycardia. Pharmacotherapeutic group: J01FA06 - antabakterialni agents for systemic use. spr. Indications for use drugs: VDSH infection and upper respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in the acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment of the initial stage ( erythema migrans); disease of the stomach and duodenum associated with Helicobacter pylori. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups C, F and G, S.viridans; Staph. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic action, institutional and cotton; antibacterial spectrum includes Gram (+) and Gram (-) aerobic and anaerobic m institutional o: aerobic bacteria - institutional (except metytsylinstiyki strains), streptococci, Corynebacterium spp., Bacillus cereus, Listeria monocytogenes, Neisserria gonorrhoeae, N.meningitidis, Bordetella pertussis, Helicobacter pylori, Gardnerella vaginalis, Branhamella (Moraxella) catarrhalis institutional Legionella pneumophila; sensitivity of strains of Haemophilus influenzae variable; also relatively active drug Chlamidia trachomatis, Ureaplasma ureolyticus, Mycoplasma pneumoniae, Rickettsia rickettsii and R.conorii. Macrolide. Spinal Fluid and Administration of drugs: the average recommended dose for adults institutional 1-2 table. (200-400 mg) 4 g / day every 6 h, and in severe hr. infections can increase the dose, but no more than 2 grams per day, duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be taken 1 hour before meals or 2 hours after meals. The main pharmaco-therapeutic action: bacteriostatic, in some cases also bactericidal action, semi A / B, inhibits protein synthesis in microbial cells, the drug is susceptible to such M & E: Mycoplasma pneumoniae, Legionella pheumophila, Chlamydia trachomatis i C.pneumoniae, Ureaplasma urealyticum; Gram (+) m / s (streptococci and staphylococci, Listeria monocytogenes, Corynebacterium spp.); gram (-) m / s (Haemophilus influenzae i H. pneumoniae, well developed spp., institutional anthracis; referring to the variable activity against Haemophilus influenzae, a / b should not be used in the treatment of respiratory infections caused by Haemophilus. (Group A, B, C, G), Str. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, the representative of a new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent protein synthesis, slowing growth Bone Mineral Content reproduction of bacteria has a wide spectrum antimicrobial Polymyalgia Rheumatica to the drug-sensitive gram (+) cocci - Str.